載入...
Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI): characterizing disease severity and assessing responsiveness to clinical change
BACKGROUND: The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) was developed for use in clinical trials and longitudinal patient assessment. OBJECTIVES: To characterize disease severity using the CDASI and assess responsiveness of this instrument to clinically meaningful changes i...
Na minha lista:
| 發表在: | Br J Dermatol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878996/ https://ncbi.nlm.nih.gov/pubmed/25994337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.13915 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|